For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250410:nRSJ5272Ea&default-theme=true
RNS Number : 5272E Advanced Medical Solutions Grp PLC 10 April 2025
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Advanced Medical Solutions Group PLC
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a
trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form Advanced Medical Solutions Group PLC
relates:
Use a separate form for each offeror/offeree
(d) Is the discloser the offeror or the offeree? Offeree
(e) Date position held: 9 April 2025
The latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making N/A
disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates
Class of relevant security: Ordinary Shares of 5 pence each
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: Nil Nil Nil Nil
(2) Cash-settled derivatives: Nil Nil Nil Nil
(3) Stock-settled derivatives (including options) and agreements to Nil Nil Nil Nil
purchase/sell:
Nil Nil Nil Nil
TOTAL:
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: NONE
Details, including nature of the rights concerned and relevant percentages: NONE
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO
THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including
directors' and other employee options) of any person acting in concert with
the party to the offer making the disclosure:
Interests of directors
Advanced Medical Solutions Group PLC ordinary shares held by directors of
Advanced Medical Solutions Group PLC:
Name Number of AMS Shares Percentage of AMS existing issued ordinary share capital
Christopher Meredith 1,728,006(1) 0.79%
Edward Johnson 73,957(2) 0.0033%
Grahame Cook 48,864 0.0022%
(1)Includes 1,376,496 shares held by Christopher Meredith's close relatives.
(2)Includes 19,044 shares held by Edward Johnson's close relative.
Interests held as options or awards by directors of Advanced Medical Solutions
Group PLC in ordinary shares of Advanced Medical Solutions Group PLC:
(A) Christopher Meredith
(i) Employee Share Purchase Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
32,010 05/05/2020 05/05/2023 05/05/2030 Nil
26,388 11/05/2021 11/05/2024 11/05/2031 Nil
28,060 12/05/2022 12/05/2022 12/05/2031 Nil
56,120 12/05/2022 12/05/2025 12/05/2032 Nil
13,143 17/05/2023 17/05/2023 17/05/2033 Nil
26,286 17/05/2023 17/05/2026 17/05/2033 Nil
25,288 11/11/2024 11/11/2024 11/11/2034 Nil
50,576 11/11/2024 11/11/2027 11/11/2034 Nil
(ii) Share Incentive Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
586 30/04/2018 30/04/2018 30/04/2028 Nil
586 30/04/2018 30/04/2021 30/04/2028 Nil
545 29/04/2019 29/04/2019 29/04/2029 Nil
545 29/04/2019 29/04/2022 29/04/2029 Nil
734 05/05/2020 05/05/2020 05/05/2030 Nil
734 05/05/2020 05/05/2023 05/05/2030 Nil
661 11/05/2021 11/05/2021 11/05/2031 Nil
661 11/05/2021 11/05/2024 11/05/2031 Nil
665 12/05/2022 12/05/2022 12/05/2032 Nil
665 12/05/2022 12/05/2025 12/05/2032 Nil
716 17/05/2023 17/05/2023 17/05/2033 Nil
1,432 17/05/2023 17/05/2026 17/05/2033 Nil
801 11/11/2024 11/11/2024 11/11/2034 Nil
1,602 11/11/2024 11/11/2027 11/11/2034 Nil
(iii) Long Term Incentive Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
132,247 14/04/2020 14/04/2023 14/04/2030 Nil
238,963 23/04/2021 23/04/2024 23/04/2031 Nil
239,552 14/04/2022 14/04/2025 14/04/2032 Nil
324,805 14/04/2023 14/04/2026 14/04/2033 Nil
411,478 23/04/2024 23/04/2027 23/04/2034 Nil
(iv) Deferred Bonus Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
6,219 14/04/2022 14/04/2025 14/04/2032 Nil
31,138 14/04/2023 14/04/2026 14/04/2033 Nil
(B) Edward Johnson
(i) Employee Share Purchase Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
8,201 03/05/2016 03/05/2016 03/05/2026 Nil
16,402 03/05/2016 03/05/2019 03/05/2026 Nil
6,476 02/05/2017 02/05/2017 02/05/2027 Nil
12,952 02/05/2017 02/05/2020 02/05/2027 Nil
12,518 30/04/2018 30/04/2021 30/04/2028 Nil
6,259 30/04/2018 30/04/2018 30/04/2028 Nil
3,302 29/04/2019 29/04/2019 29/04/2029 Nil
6,604 29/04/2019 29/04/2022 29/04/2029 Nil
9,830 05/05/2020 05/05/2020 05/05/2030 Nil
19,660 05/05/2020 05/05/2023 05/05/2030 Nil
8,945 11/05/2021 11/05/2021 11/05/2031 Nil
17,890 11/05/2021 11/05/2024 11/05/2031 Nil
8,280 12/05/2022 12/05/2022 12/05/2032 Nil
16,560 12/05/2022 12/05/2025 12/05/2032 Nil
19,252 17/05/2023 17/05/2023 17/05/2033 Nil
38,504 17/05/2023 17/05/2026 17/05/2033 Nil
16,428 11/11/2024 11/11/2024 11/11/2034 Nil
32,856 11/11/2024 11/11/2027 11/11/2034 Nil
(ii) Share Incentive Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
1,428 30/04/2014 30/04/2014 TBC* Nil
1,428 30/04/2014 30/04/2014 TBC* Nil
1,271 29/04/2015 29/04/2015 29/04/2025 Nil
1,271 29/04/2015 29/04/2018 29/04/2025 Nil
983 03/05/2016 03/05/2016 03/05/2026 Nil
983 03/05/2016 03/05/2019 03/05/2026 Nil
681 02/05/2017 02/05/2017 02/05/2027 Nil
681 02/05/2017 02/05/2020 02/05/2027 Nil
586 30/04/2018 30/04/2018 30/04/2028 Nil
586 30/04/2018 30/04/2021 30/04/2028 Nil
545 29/04/2019 29/04/2019 29/04/2029 Nil
545 29/04/2019 29/04/2022 29/04/2029 Nil
734 05/05/2020 05/05/2020 05/05/2030 Nil
734 05/05/2020 05/05/2023 05/05/2030 Nil
661 11/05/2021 11/05/2021 11/05/2031 Nil
661 11/05/2021 11/05/2024 11/05/2031 Nil
665 12/05/2022 12/05/2022 12/05/2032 Nil
665 12/05/2022 12/05/2025 12/05/2032 Nil
716 17/05/2023 17/05/2023 17/05/2033 Nil
1,432 17/05/2023 17/05/2026 17/05/2033 Nil
801 11/11/2024 11/11/2024 11/11/2034 Nil
1,602 11/11/2024 11/11/2027 11/11/2034 Nil
*These awards would ordinarily have expired on 30 April 2024, but were unable
to be withdrawn due to a number of closed periods. The intention is for these
awards to be withdrawn in 2025.
(iii) Long Term Incentive Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
28,126 18/04/2016 18/04/2019 18/04/2026 Nil
17,379 06/04/2017 06/04/2020 06/04/2027 Nil
8,221 24/04/2019 24/04/2022 24/04/2029 Nil
37,470 14/04/2020 14/04/2023 14/04/2030 Nil
67,706 23/04/2021 23/04/2024 23/04/2031 Nil
89,832 14/04/2022 14/04/2025 14/04/2032 Nil
134,063 14/04/2023 14/04/2026 14/04/2033 Nil
169,837 23/04/2024 23/04/2027 23/04/2034 Nil
(iv) Deferred Bonus Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
4,556 06/04/2017 06/04/2020 06/04/2027 Nil
4,089 13/04/2018 13/04/2021 13/04/2028 Nil
2,209 24/04/2019 24/04/2022 24/04/2029 Nil
1,883 14/04/2022 14/04/2025 14/04/2032 Nil
13,528 14/04/2023 14/04/2026 14/04/2033 Nil
(1)Includes 1,376,496 shares held by Christopher Meredith's close relatives.
(2)Includes 19,044 shares held by Edward Johnson's close relative.
Interests held as options or awards by directors of Advanced Medical Solutions
Group PLC in ordinary shares of Advanced Medical Solutions Group PLC:
(A) Christopher Meredith
(i) Employee Share Purchase Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
32,010 05/05/2020 05/05/2023 05/05/2030 Nil
26,388 11/05/2021 11/05/2024 11/05/2031 Nil
28,060 12/05/2022 12/05/2022 12/05/2031 Nil
56,120 12/05/2022 12/05/2025 12/05/2032 Nil
13,143 17/05/2023 17/05/2023 17/05/2033 Nil
26,286 17/05/2023 17/05/2026 17/05/2033 Nil
25,288 11/11/2024 11/11/2024 11/11/2034 Nil
50,576 11/11/2024 11/11/2027 11/11/2034 Nil
(ii) Share Incentive Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
586 30/04/2018 30/04/2018 30/04/2028 Nil
586 30/04/2018 30/04/2021 30/04/2028 Nil
545 29/04/2019 29/04/2019 29/04/2029 Nil
545 29/04/2019 29/04/2022 29/04/2029 Nil
734 05/05/2020 05/05/2020 05/05/2030 Nil
734 05/05/2020 05/05/2023 05/05/2030 Nil
661 11/05/2021 11/05/2021 11/05/2031 Nil
661 11/05/2021 11/05/2024 11/05/2031 Nil
665 12/05/2022 12/05/2022 12/05/2032 Nil
665 12/05/2022 12/05/2025 12/05/2032 Nil
716 17/05/2023 17/05/2023 17/05/2033 Nil
1,432 17/05/2023 17/05/2026 17/05/2033 Nil
801 11/11/2024 11/11/2024 11/11/2034 Nil
1,602 11/11/2024 11/11/2027 11/11/2034 Nil
(iii) Long Term Incentive Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
132,247 14/04/2020 14/04/2023 14/04/2030 Nil
238,963 23/04/2021 23/04/2024 23/04/2031 Nil
239,552 14/04/2022 14/04/2025 14/04/2032 Nil
324,805 14/04/2023 14/04/2026 14/04/2033 Nil
411,478 23/04/2024 23/04/2027 23/04/2034 Nil
(iv) Deferred Bonus Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
6,219 14/04/2022 14/04/2025 14/04/2032 Nil
31,138 14/04/2023 14/04/2026 14/04/2033 Nil
(B) Edward Johnson
(i) Employee Share Purchase Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
8,201 03/05/2016 03/05/2016 03/05/2026 Nil
16,402 03/05/2016 03/05/2019 03/05/2026 Nil
6,476 02/05/2017 02/05/2017 02/05/2027 Nil
12,952 02/05/2017 02/05/2020 02/05/2027 Nil
12,518 30/04/2018 30/04/2021 30/04/2028 Nil
6,259 30/04/2018 30/04/2018 30/04/2028 Nil
3,302 29/04/2019 29/04/2019 29/04/2029 Nil
6,604 29/04/2019 29/04/2022 29/04/2029 Nil
9,830 05/05/2020 05/05/2020 05/05/2030 Nil
19,660 05/05/2020 05/05/2023 05/05/2030 Nil
8,945 11/05/2021 11/05/2021 11/05/2031 Nil
17,890 11/05/2021 11/05/2024 11/05/2031 Nil
8,280 12/05/2022 12/05/2022 12/05/2032 Nil
16,560 12/05/2022 12/05/2025 12/05/2032 Nil
19,252 17/05/2023 17/05/2023 17/05/2033 Nil
38,504 17/05/2023 17/05/2026 17/05/2033 Nil
16,428 11/11/2024 11/11/2024 11/11/2034 Nil
32,856 11/11/2024 11/11/2027 11/11/2034 Nil
(ii) Share Incentive Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
1,428 30/04/2014 30/04/2014 TBC* Nil
1,428 30/04/2014 30/04/2014 TBC* Nil
1,271 29/04/2015 29/04/2015 29/04/2025 Nil
1,271 29/04/2015 29/04/2018 29/04/2025 Nil
983 03/05/2016 03/05/2016 03/05/2026 Nil
983 03/05/2016 03/05/2019 03/05/2026 Nil
681 02/05/2017 02/05/2017 02/05/2027 Nil
681 02/05/2017 02/05/2020 02/05/2027 Nil
586 30/04/2018 30/04/2018 30/04/2028 Nil
586 30/04/2018 30/04/2021 30/04/2028 Nil
545 29/04/2019 29/04/2019 29/04/2029 Nil
545 29/04/2019 29/04/2022 29/04/2029 Nil
734 05/05/2020 05/05/2020 05/05/2030 Nil
734 05/05/2020 05/05/2023 05/05/2030 Nil
661 11/05/2021 11/05/2021 11/05/2031 Nil
661 11/05/2021 11/05/2024 11/05/2031 Nil
665 12/05/2022 12/05/2022 12/05/2032 Nil
665 12/05/2022 12/05/2025 12/05/2032 Nil
716 17/05/2023 17/05/2023 17/05/2033 Nil
1,432 17/05/2023 17/05/2026 17/05/2033 Nil
801 11/11/2024 11/11/2024 11/11/2034 Nil
1,602 11/11/2024 11/11/2027 11/11/2034 Nil
*These awards would ordinarily have expired on 30 April 2024, but were unable
to be withdrawn due to a number of closed periods. The intention is for these
awards to be withdrawn in 2025.
(iii) Long Term Incentive Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
28,126 18/04/2016 18/04/2019 18/04/2026 Nil
17,379 06/04/2017 06/04/2020 06/04/2027 Nil
8,221 24/04/2019 24/04/2022 24/04/2029 Nil
37,470 14/04/2020 14/04/2023 14/04/2030 Nil
67,706 23/04/2021 23/04/2024 23/04/2031 Nil
89,832 14/04/2022 14/04/2025 14/04/2032 Nil
134,063 14/04/2023 14/04/2026 14/04/2033 Nil
169,837 23/04/2024 23/04/2027 23/04/2034 Nil
(iv) Deferred Bonus Plan
No. of Options/ Awards Date of grant Vesting date Expiry date Exercise price (£)
4,556 06/04/2017 06/04/2020 06/04/2027 Nil
4,089 13/04/2018 13/04/2021 13/04/2028 Nil
2,209 24/04/2019 24/04/2022 24/04/2029 Nil
1,883 14/04/2022 14/04/2025 14/04/2032 Nil
13,528 14/04/2023 14/04/2026 14/04/2033 Nil
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial
collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the party to
the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state "none"
None.
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the party to the offer making the disclosure, or any person acting in
concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None.
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO
Supplemental Form 8 (SBL) NO
Date of disclosure: 10 April 2025
Contact name: Owen Bromley, Company Secretary
Telephone number: 01606 545514
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FEEIMMMTMTTBBAA